+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Bevacizumab"

Asia-Pacific Colorectal Cancer Market to 2028 - Regional Analysis and Forecasts by Modality; End User, and Country - Product Thumbnail Image

Asia-Pacific Colorectal Cancer Market to 2028 - Regional Analysis and Forecasts by Modality; End User, and Country

  • Report
  • September 2022
  • 185 Pages
  • Asia Pacific
From
Middle East & Africa Colorectal Cancer Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Modality and End User - Product Thumbnail Image

Middle East & Africa Colorectal Cancer Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Modality and End User

  • Report
  • September 2022
  • 162 Pages
  • Middle East, Africa
From
South & Central America Colorectal Cancer Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Modality and End User - Product Thumbnail Image

South & Central America Colorectal Cancer Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Modality and End User

  • Report
  • September 2022
  • 152 Pages
From
North America Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality; End User, and Country - Product Thumbnail Image

North America Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality; End User, and Country

  • Report
  • September 2022
  • 157 Pages
  • North America
From
Europe Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality; End User, and Country - Product Thumbnail Image

Europe Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality; End User, and Country

  • Report
  • September 2022
  • 181 Pages
  • Europe
From
Colorectal Cancer Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Modality and End-user - Product Thumbnail Image

Colorectal Cancer Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Modality and End-user

  • Report
  • June 2022
  • 259 Pages
  • Global
From
Solid Tumor Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Solid Tumor Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 114 Pages
  • Global
From
Global Fallopian Tube Cancer Market - Segmented by Therapy Type, and Geography - Growth, Trends, and Forecast (2018 - 2023) - Product Thumbnail Image

Global Fallopian Tube Cancer Market - Segmented by Therapy Type, and Geography - Growth, Trends, and Forecast (2018 - 2023)

  • Report
  • April 2018
  • 112 Pages
  • Global
From
Olaparib + bevacizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Olaparib + bevacizumab Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Metastatic Colorectal Cancer - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Metastatic Colorectal Cancer - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • February 2022
  • 308 Pages
  • Global
From
Bevacizumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Bevacizumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 125 Pages
  • Global
From
India Liver Cancer Therapeutics Market, Competition, Forecast & Opportunities, 2029 - Product Thumbnail Image

India Liver Cancer Therapeutics Market, Competition, Forecast & Opportunities, 2029

  • Report
  • October 2023
  • 89 Pages
  • India
From
Immune Checkpoint Inhibitors Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Immune Checkpoint Inhibitors Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 119 Pages
  • Global
From
CTLA-4 inhibitors- Competitive landscape, 2023 - Product Thumbnail Image

CTLA-4 inhibitors- Competitive landscape, 2023

  • Report
  • May 2023
  • 220 Pages
  • Global
From
Neuroendocrine Tumors - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Neuroendocrine Tumors - Market Insight, Epidemiology and Market Forecast -2032

  • Drug Pipelines
  • January 2022
  • 200 Pages
  • Global
From
Ovarian Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Drug Class, By Tumor Type, By Distribution Channel, By Region - Product Thumbnail Image

Ovarian Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Drug Class, By Tumor Type, By Distribution Channel, By Region

  • Report
  • November 2022
  • 117 Pages
  • Global
From
Cervical Cancer Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Cervical Cancer Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 116 Pages
  • Global
From
North America Ovarian Cancer Diagnostics and Therapeutics Market - Segmented by Cancer Type, Cancer Stage, Diagnosis, Treatment, and Geography - Growth, Trends, and Forecast (2018 - 2023) - Product Thumbnail Image

North America Ovarian Cancer Diagnostics and Therapeutics Market - Segmented by Cancer Type, Cancer Stage, Diagnosis, Treatment, and Geography - Growth, Trends, and Forecast (2018 - 2023)

  • Report
  • March 2018
  • 90 Pages
  • North America
From
Investigation Report on China's Bevacizumab Market 2021-2025 - Product Thumbnail Image

Investigation Report on China's Bevacizumab Market 2021-2025

  • Report
  • April 2021
  • 50 Pages
  • China
From
Colorectal Cancer KOL Interview - UK - Product Thumbnail Image

Colorectal Cancer KOL Interview - UK

  • Newsletter
  • May 2024
  • 14 Pages
  • United Kingdom
Loading Indicator

Bevacizumab is a monoclonal antibody used in the treatment of various types of cancer. It is used in combination with other drugs to treat metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, metastatic renal cell carcinoma, and metastatic breast cancer. Bevacizumab works by inhibiting the growth of new blood vessels, which can help slow the growth of tumors. It is administered intravenously and is typically given in combination with other chemotherapy drugs. Bevacizumab is a widely used drug in the oncology market, and is one of the most prescribed drugs for cancer treatment. It is used in combination with other drugs to treat a variety of cancers, and is often used in combination with chemotherapy. Bevacizumab has been shown to be effective in treating certain types of cancer, and is generally well tolerated. Some companies in the Bevacizumab market include Genentech, Roche, Pfizer, Merck, and Bristol-Myers Squibb. Show Less Read more